Itzel Valencia

Itzel Valencia

Auto-generated profile, based on publicly available information

Itzel Valencia

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2023 in Blood
Verified
Journal Article
Closed access
PDF file
ASAleksandr Sarachakov
Aleksandr Sarachakov
AVArina Varlamova
Arina Varlamova
VSViktor Svekolkin
Viktor Svekolkin
MPMargarita Polyakova
Margarita Polyakova
IVItzel Valencia
Itzel Valencia
SPSanjay Patel
Sanjay Patel
The spatial anatomy of hematopoiesis in the bone marrow (BM) has been extensively studied in mice and other preclinical models, but technical challenges have precluded a commensurate exploration in humans. Institutional pathology archives contain thousands of paraffinized BM core biopsy tissue specimens, providing a rich resource for studying the intact human BM topography in a variety of physiologic states. Thus, we developed an end-to-end pipeline involving multiparameter whole tissue staining, in situ imaging at single-cell resolution, and artificial intelligence–based digital whole slide image analysis and then applied it to a cohort of disease-free samples to survey alterations in the hematopoietic topography associated with aging. Our data indicate heterogeneity in marrow adipose tissue (MAT) content within each age group and an inverse correlation between MAT content and proportions of early myeloid and erythroid precursors, irrespective of age. We identify consistent endosteal and perivascular positioning of hematopoietic stem and progenitor cells (HSPCs) with medullary localization of more differentiated elements and, importantly, uncover new evidence of aging-associated changes in cellular and vascular morphologies, microarchitectural alterations suggestive of foci with increased lymphocytes, and diminution of a potentially active megakaryocytic niche. Overall, our findings suggest that there is topographic remodeling of human hematopoiesis associated with aging. More generally, we demonstrate the potential to deeply unravel the spatial biology of normal and pathologic human BM states using intact archival tissue specimens.

29 July 2025 in Laboratory Investigation
Verified
Journal Article
Closed access
MOMohamed Omar
Mohamed Omar
Giuseppe Nicolò FanelliGiuseppe Nicolò Fanelli
Giuseppe Nicolò Fanelli
FSFabio Socciarelli
Fabio Socciarelli
VUVarun Ullanat
Varun Ullanat
SPSreekar Reddy Puchala
Sreekar Reddy Puchala
MLMassimo F. Loda
Massimo F. Loda

29 January 2024 in Molecular Cancer Research
Verified
Journal Article
Open access
PDF file
MOMohamed Omar
Mohamed Omar
ZXZhuoran Xu
Zhuoran Xu
SRSophie B. Rand
Sophie B. Rand
MAMohammad K. Alexanderani
Mohammad K. Alexanderani
DSDaniela C. Salles
Daniela C. Salles
LMLuigi Marchionni
Luigi Marchionni
Prostate cancer harbors several genetic alterations, the most prevalent of which is TMPRSS2:ERG gene fusion, affecting nearly half of all cases. Capitalizing on the increasing availability of whole-slide images (WSI), this study introduces a deep learning (DL) model designed to detect TMPRSS2:ERG fusion from H&E-stained WSIs of radical prostatectomy specimens. Leveraging the TCGA prostate adenocarcinoma cohort, which comprises 436 WSIs from 393 patients, we developed a robust DL model, trained across 10 different splits, each consisting of distinct training, validation, and testing sets. The model's best performance achieved an AUC of 0.84 during training, and 0.72 on the TCGA test set. This model was subsequently validated on an independent cohort comprising 314 WSIs from a different institution, in which it has a robust performance at predicting TMPRSS2:ERG fusion with an AUC of 0.73. Importantly, the model identifies highly-attended tissue regions associated with TMPRSS2:ERG fusion, characterized by higher neoplastic cell content and altered immune and stromal profiles compared with fusion-negative cases. Multivariate survival analysis revealed that these morphologic features correlate with poorer survival outcomes, independent of Gleason grade and tumor stage. This study underscores the potential of DL in deducing genetic alterations from routine slides and identifying their underlying morphologic features, which might harbor prognostic information. Implications: Our study illuminates the potential of deep learning in effectively inferring key prostate cancer genetic alterations from the tissue morphology depicted in routinely available histology slides, offering a cost-effective method that could revolutionize diagnostic strategies in oncology.

31 August 2024 in medRxiv
Verified
Preprint
Open access
PDF file
IVItzel Valencia
Itzel Valencia
PNPier Vitale Nuzzo
Pier Vitale Nuzzo
EFEdoardo Francini
Edoardo Francini
FRFrancesco Ravera
Francesco Ravera
GFGiuseppe Nicolò Fanelli
Giuseppe Nicolò Fanelli
MOMohamed Omar
Mohamed Omar
Prostate cancer (PCa) is currently the most commonly diagnosed cancer and second leading cause of cancer-related death in men in the United States. The development of metastases is associated with a poor prognosis in PCa patients. Since current clinicopathological classification schemes are unable to accurately prognosticate the risk of metastasis for those diagnosed with localized PCa, there is a pressing need for precise and easily attainable biomarkers of metastatic risk in these patients. Primary tumor samples from 1239 individuals with PCa were divided into development (n=1000) and validation (n=239) cohorts. In the development cohort, we utilized a meta-analysis workflow on retrospective primary tumor gene expression profiles to identify a subset of genes predictive of metastasis. For each gene, we computed Hedges’ g effect size and combined their p-values using Fisher’s combined probability test. We then adjusted for multiple hypothesis testing using the Benjamini-Hochberg method. Our developed gene signature, termed Meta-Score, achieved a robust performance at predicting metastasis from primary tumor gene expression profiles, with an AUC of 0.72 in the validation cohort. In addition to its robust predictive power, Meta-Score also demonstrated a significant prognostic utility in two independent cohorts. Specifically, patients with a higher risk-score had a significantly worse metastasis-free survival and progression-free survival compared to those with lower score. Multivariate cox proportional hazards model showed that Meta-Score is significantly associated with worse survival even after adjusting for Gleason score. Our findings suggest that our primary tumor transcriptional signature, Meta-Score, could be a valuable tool to assess the risk of metastasis in PCa patients with localized disease, pending validation in large prospective studies. Author Summary: Metastasis is the leading cause of death in patients diagnosed with prostate cancer (PCa), underscoring the need for reliable prediction tools to forecast the risk of metastasis at an early stage. Here, we utilize the gene expression profiles of 1,000 unique primary tumors from patients with localized PCa to develop a gene signature capable of predicting metastasis. Our signature, termed Meta-Score, comprises forty-five genes that can accurately distinguish primary tumor with high propensity for metastasis across different patient cohorts. Notably, Meta-Score maintained its robust predictive performance in an internal validation cohort of comprising primary tumor samples from 239 patients. In addition to its robust predictive performance, Meta-Score demonstrates a significant association with survival, independent of Gleason score in two independent patient cohorts, underscoring its prognostic utility. Taken together, Meta-Score is a robust risk-stratification tool that can be leveraged to identify patients at high-risk of metastasis and unfavorable survival using their primary tumor gene expression profiles.

3 June 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
PSPaul D. Simonson
Paul D. Simonson
IVItzel Valencia
Itzel Valencia
SPSanjay Patel
Sanjay Patel
Multiparametric imaging allows researchers to measure the expression of many biomarkers simultaneously, allowing detailed characterization of cell microenvironments. One such technique, CODEX, allows fluorescence imaging of >30 proteins in a single tissue section. In the commercial CODEX system, primary antibodies are conjugated to DNA barcodes. This modification can result in antibody dysfunction, and development of a custom antibody panel can be very costly and time consuming as trial and error of modified antibodies proceeds. To address these challenges, we developed novel tyramide-conjugated DNA barcodes that can be used with primary antibodies via peroxidase-conjugated secondary antibodies. This approach results in signal amplification and imaging without the need to conjugate primary antibodies. When combined with commercially available barcode-conjugated primary antibodies, we can very quickly develop working antibody panels. We also present methods to perform antibody staining using a commercially available automated tissue stainer and in situ hybridization imaging on a CODEX platform.

17 June 2026
Verified
Other
Open access
MOMohamed Omar
Mohamed Omar
ZXZhuoran Xu
Zhuoran Xu
SRSophie B. Rand
Sophie B. Rand
MAMohammad K. Alexanderani
Mohammad K. Alexanderani
DSDaniela C. Salles
Daniela C. Salles
LMLuigi Marchionni
Luigi Marchionni
Supplementary Figure 1. Progression-free survival in the TCGA cohort using the cellular composition of the whole slide images. Kaplan-Meier curves showing the association between the fraction of each nuclear type and progression-free survival. The fraction of each cell type was calculated by dividing the absolute number of that cell type over the number of all cells in the whole slide. The stromal to neoplastic ratio was calculated by dividing the number of stromal cells by that of neoplastic cells in the whole slide. These fractions were then then binarized into high versus low using maximally selected log-rank statistics.